In addition to senile plaques, neurofibrillary tangles are characteristic of Alzheimer's disease (AD) pathology, suggesting a clear involvement of the microtubule-associated protein tau (MAPT) in AD. Recent findings, suggesting that the H1c haplotype is associated with increased risk, now also implicate MAPT genetically. In this study, we aim to clarify this association by a fine mapping approach using both a traditional phenotypic association analysis and a quantitative trait (QT) analysis using cerebrospinal fluid (CSF) tau protein levels in the German population. Here, we report that both methodologies identify that the H1c haplotype may play important role in AD (AD risk, P = 0.007, uncorrected; CSF tau levels, P = 0.027, uncorrected). Further, the use of a sliding window approach in the QT analysis allowed for the narrowing down of the region where a probable causal variant may be located. The data suggest that this may lie at or within close proximity to the rs242557 single nucleotide polymorphism as association with CSF tau levels seems to be primarily driven by rs242557 in a gene dosagedependent manner (trend model: P = 0.002, uncorrected). These findings provide functional evidence to support the genetic association of MAPT with AD.
Introduction
The Tauopathies comprise a clinically variable group of neurodegenerative diseases with overlapping clinical and neuropathological features, 1 which have common characteristic neuropathology of abnormal tau protein filaments. Tau is a microtubule (MT)-associated protein involved in the promotion of MT assembly, increasing of MT stability and maintaining neuronal integrity and axonal transport. 2, 3 Disorders that have been categorized under the term of tauopathies include, but are not limited to; Alzheimer's disease (AD, MIM 104300) and other phenotypes covered by the label Frontotemporal Dementia (FTD, MIM 600274)/Pick complex. [4] [5] [6] [7] Some of these diseases grouped under this concept have been associated with mutations in the gene encoding the MT-associated protein tau (MAPT; MIM 157140) located at chromosome 17q21.1. 8, 9 The region containing MAPT contains two extended haplotypes, termed H1 and H2, the occurrence of which is suggested to be an ancient event 10 and in which studies suggest an absence of recombination. 11 These two clades can be delineated via the a 238 bp insertion/deletion polymorphism within intron 9 (del-In9). 10, 12, 13 Association studies of H1 versus H2, in AD have to date produced largely negative findings. [13] [14] [15] [16] Recent studies have reported that whereas the H2 haplotype is in fact a single nonrecombining haplotype, the more common H1 haplotype is more diverse, showing typical linkage disequilibrium (LD), although not with H2. 12, [17] [18] [19] This diversity can be tagged through five single-nucleotide polymorphisms (SNPs) and the aforementioned delIn9. 13, 16 The H1c variant of this haplotype is reported to be the predominant cause of the H1 association with progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) 17, 20, 21 and more recently has been associated with AD. 16 Prior studies of MAPT associations with AD had produced inconclusive findings; 14, 15, [22] [23] [24] [25] however, the study of Myers et al. 16 was the first study to assess the impact of this H1 diversity. It was previously clear that tau was intimately involved in AD pathology, owing to neurofibrillary tangles, along with senile plaques, being the characteristic pathological hallmarks of the disease. However, this recent finding now also implicates MAPT genetically with sporadic forms of AD. The mechanism by which the H1c haplotype may instigate increased risk may be related to expression levels, as a prior study has reported that the H1 haplotype has an elevated transcriptional activity as compared to the H2 haplotype. 26 This higher level of expression of tau conceivably propagates neuronal degeneration. As decaying neurons are believed to be the major source of cerebrospinal fluid (CSF) tau levels, 27 we utilized this biomarker as an appropriate candidate for quantitative trait (QT) analysis. Thus, the aim of this study was to assess diversity of the H1 clade in AD individuals and perform a fine mapping approach to identify possible causal variants. Through information gained from a traditional phenotypic association study (case/control) in combination with QT analysis of total tau levels in CSF, we were able to narrow down successfully the observed association signals to a single marker.
Materials and methods

Study sample
The study refers to two separate sample series. The phenotypic association study consisted of a total of 712 Caucasian subjects comprising 433 individuals with a diagnosis of probable AD (mean age, 72.4 years standard deviation (s.d.) 9.5; age at onset, 69.3 years s.d. 9.4; 41% male) and 279 cognitively healthy controls (mean age, 67.2 years s.d. 11.6; 43% male). The QT analysis was undertaken in a cohort comprising 89 individuals who did not differ from the casecontrol cohort in terms of phenotype; however, the average age at onset (68.3 years, s.d. 9.7) was slightly younger than the full cohort and there were also a higher percentage of males (47%). Individuals from both patient series were recruited from a university memory clinic from 1994 to 2004. The control group was matched for geographical location and ethnicity and consisted of cognitively healthy subjects who were recruited from spouses of those attending the memory clinics and community based geriatric daycare units. Information on age at onset of the disease was obtained from an informant. Age at onset was defined by the appearance of first clinical symptoms. After informed consent had been obtained, blood samples of each subject were taken by venous puncture. The study protocol was approved by the review board of the medical faculty, Technische Universität Mü nchen.
The clinical diagnosis of probable AD was established according to the NINCDS-ADRDA criteria. 28 Cognitive impairment was assessed using the Cambridge Cognitive Examination 29 or, alternatively, the Consortium to Establish a Registry for Alzheimer's disease. 30 Both instruments incorporate the Mini Mental State Examination, 31 which was used to test cognitive performance in the control group. Control subjects with a MMSE score below 28 were excluded from further analysis. All patients and controls underwent a thorough psychiatric, neurological and neuropsychological evaluation. The diagnostic workup also included an informant interview, a chemistry survey, structural magnetic resonance imaging (MRI) imaging and functional imaging in patients with AD whenever possible.
Genetic analyses DNA was extracted from blood samples using standard procedures and APOE genotype was determined using polymerase chain reaction (PCR) and restriction enzyme digestion, as described previously. 32 A 238-bp insertion/deletion polymorphism within intron 9 (del-In9) of MAPT was first described by Baker et al. 10 and the presence of the 238-bp insertion has been shown to tag all H1 haplotypes, 16 thus allowing the differentiation of the H1/H2 haplotypes. Analysis of del-In9 was performed as described previously. 10 Genotyping of the tagging SNPs rs1467967 (NT_010783.14:g.2640285A > G), rs242557 (NT_010783.14:g.2673852G < A), rs3785883 (NT_010783.14:g.2708548G < A), rs2471738 (NT_ 010783.14:g.2730179C < T) and rs7521 (NT_010783.14: g.2759521G < A) was performed through a polymerase chain reaction-based primer extension reaction and detection of the allele-specific extension products by matrix-associated laser desorption/ionization time of flight (MALDI-TOF) mass spectrometry (Sequenom, San Diego, CA, USA) at the Department of Psychiatry, Munich. Primer sequences are available upon request. The average call rate for all SNPs was above 98%.
CSF tau levels Spinal taps and venous punctures had previously been performed in these individuals after written consent had been obtained. CSF (5-8 ml) was collected in sterile polypropylene tubes using atraumatic canules placed in the intervertebral space L3/L4 or L4/L5. Serum and ethylenediaminetetraacetic acid (EDTA) plasma were obtained by venous puncture. In native CSF, routine chemical parameters were within normal range in all subjects. These parameters included leukocyte and erythrocyte cell count, as well as glucose and lactate measurement, total protein content, CSF-to-serum ratio of albumin and immunoglobulin G, and a screening for oligoclonal bands. CSF was centrifuged for 10 min at 4000 g. The remaining CSF supernatants were immediately frozen, in aliquots, at À801C for subsequent analysis of Ab42 and tau levels. Cerebrospinal fluid total tau (Innogenetics, Gent, Belgium K 1032) concentrations were measured in duplicate by an enzyme-linked immunosorbant assay (ELISA), as described elsewhere. 33, 34 In particular, the tau ELISA uses the monoclonal antibody AT 120, which recognizes amino acids 218-224 as capturing antibodies 33 and a pair of monoclonal antibodies, HT7 (amino acids 159-163) and BT2 (amino acids 194-198) for detection.
Statistical analysis
Genotype distributions of all SNPs were in HardyWeinberg equilibrium within the control group. LD was estimated by D 0 and r 2 as implemented in Haploview. 35 Allelic/haplotypic associations were calculated using w 2 tests as implemented in Haploview. 35 Corrections for multiple testing were considered if mandatory, 1000 permutations as implemented in Haploview or via Monte Carlo permutation testing.
Genotypic associations with AD were tested by logistic regression analyses, with age, gender and APOE genotype as covariates. Haplotypic associations with AD were tested by haplotype trend regression (HTR) 36 after estimation of haplotype pairs via PHASEv2. 37, 38 Only haplotypes with a frequency greater than 5% were tested for statistical association. Genotypic and haplotypic associations with CSF tau levels and changes in age of onset were tested using linear regression, correcting for duration of disease or gender and APOE genotype, respectively. Logistic and linear regression analyses, using both recessive and trend models, were undertaken in STATA SE v9.2 (StataCorp, College Station, Texas, USA).
Results
Single-locus analysis
We genotyped the intron 9 insertion-deletion (delIn9) in addition to five tagging SNPs, which together have been shown to tag the haplotype diversity within MAPT in Caucasians, in a cohort of German AD and control individuals. The single-locus associations with AD are presented in Table 1 . There was a negligible difference in the allelic frequency of the del-In9 polymorphism, used to delineate H1 and H2 clades, suggesting that without investigating H1 diversity there is no association of these two divergent clades with AD. Of the remaining five tagging SNPs, only the rs242557 SNP showed any robust association with AD, which survived both correction for multiple testing and adjustment for APOE genotype and age (allelic P-value = 0.0090 (0.048, corrected), genotypic P-value = 0.016 (0.0286, adjusted for APOE and age)). It was previously observed 16 that there was a robust interaction between these polymorphisms and APOE genotype and that the singlemarker associations observed in that study were driven by those individuals not carrying the APOE e4 allele. In our study, we were unable to replicate this finding as we observed no interaction with APOE. Additionally, there was negligible impact on levels of association observed after adjusting for both age and APOE genotype; however, the rs1467967 SNP did reach a marginal level of significance (P = 0.0498). Finally, linear regression analysis in AD individuals revealed that no polymorphism had a significant impact in altering age at onset (data not shown).
Haplotype analysis LD analysis between the aforementioned polymorphisms produced a D 0 plot for the German cohort, that was very similar to that previously reported in a UK and US series (Figure 1) . 16 The six-locus haplotype frequencies are presented in the top half of Table 2 . In support of the lack of variation, at the single-locus level, between H1 and H2 in AD, we show no association of the H2a haplotype with AD, either through simple w 2 analysis or HTR, using APOE and age as covariates. Of the remaining four 6-locus haplotypes (with a frequency greater than 5%) only the H1c haplotype presented with any significant association with AD and which survived corrections for multiple testing. The H1d haplotype did show a trend towards association with AD; however, this survived neither correction for multiple testing nor adjustment for APOE and age. It had been suggested that the most likely region for a pathogenic variant(s) to occur was between rs242557 and rs2471738, which gave significant single-locus results in the study of Myers et al. 16 As such we also investigated the threelocus haplotype that was generated by these two SNPs and the intervening SNP, rs3785883 ( Table 2) . As expected, the only three-locus haplotype that was significantly associated with AD contained the alleles AGT, corresponding to those present in the H1c haplotype. However, this analysis, as compared to the 6-locus haplotype, did not improve the level of significance.
QT analysis -CSF total tau levels In light of the association of the H1 clade with increases in transcriptional activity 26 and further with the report that the rs242557 SNP may alter transcriptional activity, 21 we utilized CSF total tau levels as a quantitative trait to determine association of single markers and haplotypes (Table 3) . Single-marker linear regression analysis, adjusting for duration of disease, revealed that in both a recessive and trend model the rs242557-A allele was associated with elevated total tau levels. The trend-based model suggested a gene dosage-dependent effect on elevating tau levels, which when presented graphically ( Figure 2 ) is clearly evident; however, this is mainly due to differences between the two homozygote forms as a subsequent post hoc analysis (one-way analysis of variance (ANOVA) with Tukey's honestly significant difference (HSD) analysis) revealed that significant differences were due to homozygote extremes (AA vs GG, P-value = 0.009). Linear regression analy- . These values are similar to those reported previously 16 and again show that all markers are in linkage disequilibrium with marker 5 (del-In9), suggesting H1 specificity. a Haplotype IDs were assigned using prior nomenclature. 13 Only six-and three-locus haplotypes with a frequency greater than 5% are shown above and only these were used for the statistical analyses mentioned. Significant P-values are in bold. b Haploview analysis was undertaken using w 2 analysis, as implemented by Haploview. c Haploview analysis was undertaken using w 2 analysis, corrected via permutation testing (1000 permutations), as implemented by Haploview. d Haplotypic associations were performed using logistic haplotype trend regression (HTR) after estimation of haplotype pairs via PHASE. e Haplotypic associations were performed using logistic haplotype trend regression (HTR) after estimation of haplotype pairs via PHASE and corrected for APOE and age, all haplotypes entered into model simultaneously. f Empirical haplotypic P-values were determined after Monte Carlo permutation testing (1000 permutations) as implemented in STATA v9.2. sis based on estimated haplotype probabilities revealed the H1c haplotype as the sole six-locus haplotype significantly associated with CSF total tau levels. Subsequently, to delineate the association signal we applied a two-and three-marker locus sliding window approach (Figure 3 ). Using this approach, the strongest three-locus haplotype identified was the same as that implicated in genetic association studies. However, unlike associations with disease risk this three-locus haplotype had an improved level of significance as opposed to the six-locus haplotypes in the QT analysis. In this case, two haplotypes reached a marginal level of significance (AGC and AGT; Table 3 ), although these did not have significance levels beyond that of the single SNP, rs242557. Additionally, the strongest two-locus haplotypes identified was that generated by the rs242557 and rs3785883 SNPs. Likewise to the three-locus haplotype analysis, this analysis also did not improve upon the single-marker analysis, although it did improve upon the prior three-locus haplotype analysis (linear regression correcting for duration; haplotype, AG: Coefficient, 575.837193.27, P = 0.005).
Discussion
In addition to senile plaques, neurofibrillary tangles are characteristic of AD pathology, suggesting a clear involvement of the microtubule associated protein tau (MAPT) in AD. The recent study by Myers et al. 16 suggested that the H1c haplotype increased risk for AD, thus implicating MAPT genetically. In our study, we report that the MAPT H1c haplotype is also associated with increased risk for AD in the German population. Myers et al. 16 suggested that the most likely region for a pathogenic variant or variants to occur, based on their single-marker associations with rs242557 (5 0 of exon 1) and rs2471738 (within intron 9), was upstream of exon 1 and just within intron 9. Our findings support this notion, as a three-locus haplotype (AGT) generated by tagging SNPs in this region (rs242557-rs3785883-rs2471738) showed a similar level of association to that of the six-locus haplotype H1c. It is interesting to note that this region described by Myers and co-workers has also been described in association studies of MAPT in diseases other than AD, including PSP and Parkinson's Disease, 12, 16, 19, 21 suggesting the importance of this a Single-marker associations were determined using linear regression recessive (recessive allele (X) = associated allele, XX vs Xy,yy) model, corrected for duration of disease before CSF measurement (each SNP independently). b Single-marker associations were determined using linear regression trend (XX vs Xy vs yy) model, corrected for duration of disease before CSF measurement (each SNP independently). c Six-and three-locus haplotype associations were performed using linear haplotype trend regression (HTR), correcting for duration of disease before CSF measurement (all haplotypes entered into model simultaneously, three-and six-locus analysed separately), after estimation of Haplotype pairs via PHASE. Only six-and three-locus haplotypes with a frequency greater than 5% are shown above and only these were used for the statistical analyses mentioned. The three-locus haplotype shown is that identified via the sliding window approach (Figure 3 ). Significant P-values are in bold.
region to the spectrum of tauopathies. Although we could not replicate the association of rs2471738, we did detect a significant association of the rs242557-A allele with AD and thus suggest that, for AD, the region in the vicinity of the SNP rs242557 is likely to harbor the causal variant, be it rs242557 itself or an SNP in LD with it. This conclusion is supported by our findings from the use of CSF total tau levels as a quantitative trait. In this approach, we report that whereas the H1c haplotype was associated with elevated levels of CSF tau, we could also narrow the associated region down to the same three-locus haplotype that showed genetic risk and further to a two-locus haplotype incorporating the SNPs rs242557 and rs3785883, as haplotypes therein had increased levels of association as compared with the six-locus haplotype. However, single-marker associations revealed that these haplotype associations were driven primarily by the rs242557-A allele, which presented with the most significant levels of association. Statistical analysis revealed a trend towards a gene dosage effect of the A allele on elevating CSF tau levels; however, post hoc analysis revealed that whereas levels did increase with copy number of the A allele, the significant trend model was primarily due to differences between homozygote extremes. Prior studies have reported that the SNP rs242557 falls into a 182-bp region that is conserved in human, chimp, mouse, dog and rat. 16, 21 Rademakers et al. 21 suggested that the high degree of conservation in this region suggested the presence of functionally important cis-elements, which they subsequently confirmed through luciferase assays. Further, in silico analysis has shown that the allele A of rs242557 abolished putative binding sites for the transcription factor LBP-1c/LSF/CP2, itself implicated in AD risk, 39, 40 and the Se-Cys tRNA gene transcription-activating factor. 21 These findings suggest that the SNP rs242557 may confer differential effects on expression, a hypothesis that is given credence by both our findings and those of Rademakers et al. 21 However, in the study of Rademakers and et al. 21 the G-allele instead of the A resulted in increased luciferase activity, a finding that the authors themselves described as counterintuitive, based on their association of the A allele with disease risk. Nonetheless, it provided evidence to support differential expression at this locus, but that which should not be taken as biologically relevant as their system did not 'mimic' the in vivo situation.
Owing to the concept that CSF tau originates from decaying neurons, we cannot directly translate the higher levels observed in this study to a higher expression of tau proteins, but rather as a indicator of increased neuronal degeneration, 27 which may Figure 2 CSF total tau levels in relation to rs242557 genotype. Individual CSF levels are represented by dots with mean and standard deviation presented adjacent. Linear regression analysis controlling for duration of disease before CSF measurement revealed a significant trend for increased levels (P-value = 0.002). Carriage of the A allele (AA þ AG) was likewise associated with elevated levels compared to non-carriers (GG; P-value = 0.016). Figure 3 Sliding window analysis of two-and three-locus haplotypes with CSF total tau levels as a quantitative trait. Associations were performed using linear haplotype trend regression (HTR), correcting for duration of disease before CSF measurement (all haplotypes entered into model simultaneously, each two-and three-locus analyzed separately), after estimation of Haplotype pairs via PHASE. Only two-and three-locus haplotypes with a frequency greater than 5% were used in this analysis. Àlog 10 (P) values are indicated by circles (single locus) and full lines with either triangles (two locus) or squares (three locus). Dashed line represents a P-value of 0.05.
represent a consequence of higher expression levels. Nevertheless, these findings suggest that it is plausible that the mechanism by which the H1c haplotype confers risk for AD is via increased expression of tau protein. Elevated expression of tau has previously been shown to produce progressive neurodegeneration in Drosophila 41, 42 and that while hyperphosphorylation exacerbates this effect, overexpression alone is sufficient. 43 Further, overexpression in Drosophila has also been reported to disrupt axonal transport and produce a decline in locomotor function 44 in addition to causing significant morphological and functional disruption to the neuromuscular junctions, including defective synaptic transmission. 45 Together, these findings suggest mechanisms by which an overexpression of tau may lead to neuronal dysfunction.
In conclusion, through the use of case/control and a QT analysis, we have identified the MAPT H1c haplotype and thus support the recent association of this haplotype with increased risk for AD. Further, we support the hypothesis that the causal variant lies within a region defined by the tagging SNPs rs242557 and rs2471738. The rs242557 was found to be the only single marker to show association with AD risk and additionally we report this SNP to have a significant effect on the levels of CSF tau. These findings provide evidence to support the association of variation with MAPT with risk for AD and suggest the mechanism underlying this risk may involve differential expression and finally increased neurodegeneration. This study supports the suggestion that modulation of tau may be a viable avenue for AD therapy, as such this warrants further investigation. Additionally, the association of the region harboring the SNP rs242557 with other disease in the spectrum of tauopathies suggests that the findings in this qstudy have implications for a broader range of neurodegenerative diseases.
